Responsible for market access related topics for the German market within Pfizer's I&I and COVID-19 (antivirals) business:
- Pipeline projects of Pfizer (Market Access POC)
- Rebate contracts with sick funds
- Price negotiations within the German AMNOG regulations
- contributing to cross-functional efforts to support Pfizer's Biosimilar-portfolio
- POC for global market access colleagues
- responsible for market access matters for one of the greatest breakthroughs against the COVID-19 pandemic

Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.To learn more, visit www.pfizer.com.